SILENCE Randomized Trial: In patients at the end of life, prop | Critical Care & Emergencies

SILENCE Randomized Trial: In patients at the end of life, prophylactic subcutaneous scopolamine butylbromide reduces the occurrence of the death rattle (noisy breathing caused by mucus in the upper respiratory tract).

https://www.linksmedicus.com/news/silence-randomized-trial-patients-end-life-prophylactic-subcutaneous-scopolamine-butylbromide-reduces-occurrence-death-rattle-noisy-breathing-caused-mucus-upper-re/